Erratum to The targeting of endoglin on vascular endothelial cells affects the infiltration of M2 macrophages into the breast cancer microenvironment by modulating the interleukin-6 (IL-6) level

Erratum to: Transl Cancer Res 2018;7:912-21.

In the August 2018 issue of Translational Cancer Research, the article “The targeting of endoglin on vascular endothelial cells affects the infiltration of M2 macrophages into the breast cancer microenvironment by modulating the interleukin-6 (IL-6) level” edited by Zhang et al. (1), was published with some errors in Figure 2 due to the misuse of the Figure 2B3. Figure 2 should be corrected as below and the figure legend remains intact.

Figure 2 Infiltration of TAMs (F4/80+) and M2 macrophages (CD206+) in tumour tissues on days 7 and 14 after engraftment. (A,C) Infiltration of M2 macrophages in tumour tissues on days 7 and 14 after engraftment; (B,D) infiltration of TAMs macrophages in tumour tissues on days 7 and 14 after engraftment. *, P<0.05. TAM, tumour associated macrophage.

The authors apologize for this error, and state that this does not affect the scientific conclusions of the article.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Zhang L, Yang B, Li X, et al. The targeting of endoglin on vascular endothelial cells affects the infiltration of M2 macrophages into the breast cancer microenvironment by modulating the interleukin-6 (IL-6) level. Transl Cancer Res 2018;7:912-21.